HuGE Literature Finder
Records
1
-
5
Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC medicine 2021 Jul 19 (1): 154. Long Junyu, Wang Dongxu, Yang Xu, Wang Anqiang, Lin Yu, Zheng Mingjun, Zhang Haohai, Sang Xinting, Wang Hanping, Hu Ke, Zhao Hait |
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer. Breast cancer research : BCR 2018 Aug 20 (1): 88. Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli |
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients. Oncology research 2017 Mar . Todorova Valentina K, Makhoul Issam, Dhakal Ishwori, Wei Jeanne, Stone Annjanette, Carter Weleetka, Owen Aaron, Klimberg V Suzan |
Notch1 single nucleotide polymorphism rs3124591 is associated with the risk of development of invasive ductal breast carcinoma in a Chinese population. International journal of clinical and experimental pathology 2014 7 (7): 4286-94. Cao Yu-Wen, Wan Guo-Xing, Zhao Chun-Xia, Hu Jian-Ming, Li Li, Liang Wei-Hua, Li Wen-Qin, Li Yu-Cong, Li Yi-Xiao, Du Xiao-Ming, Yu Shi-Ying, Li Fe |
Microsatellite polymorphisms in the EGFR, NOTCH4 and E2F4 genes and their association with breast cancer risk. The International journal of biological markers 0 27 (3): e219-26. González-Hernández Ana, Henríquez-Hernández Luis Alberto, Cabrera de León Antonio, Rodríguez-Pérez M del Cristo, Murias-Rosales Adolfo, Domínguez-Coello Santiago, Brito-Díaz Buenaventura, Almeida-González Delia, Aguirre-Jaime Armando, Díaz-Chico B Nicol |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 03, 2022
- Content source: